REVISED CLINICAL PROTOCOL FOR A RANDOMIZED, DOUBLE-BLIND, CONTROLLED BY PLACEBO, STUDY TO COMPARE THE ANALGESIC ACTIVITY OF VALDECOXIB (SC-65872) 40 MG TWICE PER DAY AS ADDITIVE MEDICATION THERAPY OPIATES IN PATIENTS WITH CHRONIC CANCER PAIN

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2001
This article has no abstract
Epistemonikos ID: 2f5cd08dd2a273430b3c47c79d5a7b2b26ab91f3
First added on: Apr 16, 2025